AstraZeneca stock forecast
AstraZeneca (AZN) Stock Forecast & Price Target
AZN Analyst Ratings
AZN Stock 12 Month Forecast
Average Price Target
$214.11▲(17.47% Upside)Detailed List of Analyst Forecasts​
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Michael Leuchten | Jefferies | $231.07 | buy | 26.78%Upside | Reiterated | 11/17/26 | ||
| Emmanuel Papadakis | Deutsche Bank | $154.49→$158.45 | hold | -13.07%Downside | Reiterated | 11/06/26 | ||
| Justin Smith | Bernstein | $261.44→$270.69 | buy | 48.51%Upside | Reiterated | 11/03/26 | ||
| Rajan Sharma | Goldman Sachs | $219.20→$232.13 | buy | 27.35%Upside | Reiterated | 11/03/26 | ||
| Elmar Kraus | DZ BANK AG | ― | buy | ― | Reiterated | 11/03/26 | ||
| Colin White | UBS | $200.70→$211.27 | buy | 15.91%Upside | Reiterated | 11/02/26 | ||
| Trung Huynh | RBC Capital | $191.46→$201.36 | buy | 10.48%Upside | Reiterated | 11/02/26 | ||
| James Gordon CFA | Barclays | $211.27→$224.47 | buy | 23.15%Upside | Reiterated | 11/02/26 | ||
| Graham Parry | Citi | $245.60→$249.56 | buy | 36.92%Upside | Reiterated | 11/02/26 | ||
| Guggenheim | $213.91 | buy | 17.36%Upside | Reiterated | 11/02/26 | |||
| Sachin Jain | Bank of America Securities | ― | buy | ― | Reiterated | 10/30/26 | ||
| Richard Vosser | J.P. Morgan | $211.27 | buy | 15.91%Upside | Reiterated | 10/26/26 | ||
| Luisa Hector | Berenberg Bank | $198.06 | buy | 8.66%Upside | Reiterated | 10/16/26 | ||
| Mattias Haggblom | Nordea Markets | $162.85→$187.53 | buy | 2.88%Upside | Upgraded | 10/13/26 | ||
| Rajesh Kumar | HSBC | $181.56→$183.80 | hold | 0.84%Upside | Reiterated | 09/10/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Michael LeuchtenJefferies | BuyReiterated$231.07 | 11/17/26 | 26.78%Upside | ||
| Emmanuel PapadakisDeutsche Bank | HoldReiterated$154.49→$158.45 | 11/06/26 | -13.07%Downside | ||
| Justin SmithBernstein | BuyReiterated$261.44→$270.69 | 11/03/26 | 48.51%Upside | ||
| Rajan SharmaGoldman Sachs | BuyReiterated$219.20→$232.13 | 11/03/26 | 27.35%Upside | ||
| Elmar KrausDZ BANK AG | BuyReiterated | 11/03/26 | ― | ||
| Colin WhiteUBS | BuyReiterated$200.70→$211.27 | 11/02/26 | 15.91%Upside | ||
| Trung HuynhRBC Capital | BuyReiterated$191.46→$201.36 | 11/02/26 | 10.48%Upside | ||
| James Gordon CFABarclays | BuyReiterated$211.27→$224.47 | 11/02/26 | 23.15%Upside | ||
| Graham ParryCiti | BuyReiterated$245.60→$249.56 | 11/02/26 | 36.92%Upside | ||
| BuyReiterated$213.91 | 11/02/26 | 17.36%Upside | |||
| Sachin JainBank of America Securities | BuyReiterated | 10/30/26 | ― | ||
| Richard VosserJ.P. Morgan | BuyReiterated$211.27 | 10/26/26 | 15.91%Upside | ||
| Luisa HectorBerenberg Bank | BuyReiterated$198.06 | 10/16/26 | 8.66%Upside | ||
| Mattias HaggblomNordea Markets | BuyUpgraded$162.85→$187.53 | 10/13/26 | 2.88%Upside | ||
| Rajesh KumarHSBC | HoldReiterated$181.56→$183.80 | 09/10/26 | 0.84%Upside |
Best Analysts Covering AstraZeneca
Copying Justin Smith's trades and holding each position for 3 Months would result in 60.71% of your transactions generating a profit, with an average return of +2.30% per trade.
Copying Justin Smith's trades and holding each position for 1 Year would result in 82.14% of your transactions generating a profit, with an average return of +14.47% per trade.
Copying Richard Vosser's trades and holding each position for 2 Years would result in 90.00% of your transactions generating a profit, with an average return of +13.73% per trade.
AZN Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 4 | 6 | 7 | 4 |
| Buy | 56 | 60 | 66 | 58 | 55 |
| Hold | 1 | 1 | 4 | 5 | 7 |
| Sell | 10 | 10 | 8 | 5 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 68 | 75 | 84 | 75 | 68 |
In the current month, AZN has received 59 Buy Ratings, 7 Hold Ratings, and 2 Sell Ratings. AZN average Analyst price target in the past 3 months is 214.11.
AZN Financial Forecast
AZN Earnings Forecast
Next quarter’s earnings estimate for AZN is $2.32 with a range of $2.13 to $2.48. The previous quarter’s EPS was $2.79. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
AZN Sales Forecast
Next quarter’s sales forecast for AZN is $16.61B with a range of $16.14B to $17.20B. The previous quarter’s sales results were $16.11B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

